Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ONCOLYTICS BIOTECH INC | 566,991 | reported | 12 Feb 2026 | tx 3+200,000 |
| Aprea Therapeutics, Inc. | 45,775 | reported | 05 Jun 2025 | tx 20+429,277−263,970 |
| Aptose Biosciences Inc. | 3,333 | reported | 05 Feb 2024 | tx 4+170,333 |
Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 11 buys in history.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Feb 2026 | PURCHASE | ONCOLYTICS BIOTECH INC | 60,000 | 0.83 USD | |
| 12 Feb 2026 | PURCHASE | ONCOLYTICS BIOTECH INC | 40,000 | 0.85 USD | |
| 16 Jan 2026 | PURCHASE | ONCOLYTICS BIOTECH INC | 100,000 | 1.04 USD | first after silence |
| 05 Jun 2025 | GRANT_AWARD | Aprea Therapeutics, Inc. | 1,045 | 0.00 USD | |
| 05 Jun 2025 | GRANT_AWARD | Aprea Therapeutics, Inc. | 4,185 | 0.00 USD | deriv |
| 11 Oct 2024 | PURCHASE | Aprea Therapeutics, Inc. | 10,000 | 2.68 USD | |
| 20 Jun 2024 | GRANT_AWARD | Aprea Therapeutics, Inc. | 1,045 | 0.00 USD | |
| 20 Jun 2024 | GRANT_AWARD | Aprea Therapeutics, Inc. | 4,185 | 0.00 USD | deriv |
| 13 Mar 2024 | PURCHASE | Aprea Therapeutics, Inc. | 6,860 | 7.29 USD | |
| 13 Mar 2024 | PURCHASE | Aprea Therapeutics, Inc. | 3,430 | — | deriv |
| 13 Mar 2024 | PURCHASE | Aprea Therapeutics, Inc. | 3,430 | — | deriv |
| 05 Feb 2024 | GRANT_AWARD | Aptose Biosciences Inc. | 3,333 | 0.00 USD | deriv |
| 22 Sept 2023 | PURCHASE | Aptose Biosciences Inc. | 17,000 | 3.14 USD | |
| 23 Aug 2023 | GRANT_AWARD | Aprea Therapeutics, Inc. | 500 | 0.00 USD | |
| 23 Aug 2023 | GRANT_AWARD | Aprea Therapeutics, Inc. | 2,000 | 0.00 USD | deriv |
| 07 Jun 2023 | PURCHASE | Aprea Therapeutics, Inc. | 6,029 | 3.68 USD | |
| 06 Jun 2023 | PURCHASE | Aprea Therapeutics, Inc. | 4,068 | 3.63 USD | first after silence |
| 19 Jan 2023 | GRANT_AWARD | Aptose Biosciences Inc. | 100,000 | 0.00 USD | deriv |
| 14 Sept 2022 | GRANT_AWARD | Aptose Biosciences Inc. | 50,000 | 0.00 USD | deriv |
| 28 Jul 2022 | GRANT_AWARD | Aprea Therapeutics, Inc. | 5,995 | 0.00 USD | |
| 28 Jul 2022 | GRANT_AWARD | Aprea Therapeutics, Inc. | 29,575 | 0.00 USD | deriv |
| 18 May 2022 | PURCHASE | Aprea Therapeutics, Inc. | 50,000 | 0.71 USD | |
| 30 Jun 2021 | GRANT_AWARD | Aprea Therapeutics, Inc. | 4,610 | 0.00 USD | |
| 30 Jun 2021 | GRANT_AWARD | Aprea Therapeutics, Inc. | 22,750 | 0.00 USD | deriv |
| 30 Jun 2020 | GRANT_AWARD | Aprea Therapeutics, Inc. | 5,600 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 16 Jan 2026.